ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Journal of Long-Term Effects of Medical Implants
SJR: 0.145 SNIP: 0.491 CiteScore™: 0.89

ISSN 印刷: 1050-6934
ISSN オンライン: 1940-4379

Journal of Long-Term Effects of Medical Implants

DOI: 10.1615/JLongTermEffMedImplants.2020035511
pages 91-102

Decision Matrix-Guided Treatment of Infected Hip Resurfacing

James W. Pritchett
Hansjörg Wyss Hip and Pelvis Center, Swedish Medical Center, Seattle, WA; Orthopaedics International, 901 Boren Avenue #711, Seattle, WA 98104

要約

Infection can nullify the benefits of a successful hip resurfacing arthroplasty (HRA). Even with infection, it may be feasible to meet a patient's desire to retain the implant. The author reviewed records of 301 patients with infected hip resurfacing. Patients expressed their treatment preference using a decision matrix that considered treatment efficacy, consequences of treatment failure, probability of infection worsening, and treatment side effects. Patient interviews were analyzed to determine their experience with treatment. Treatment alternatives were (1) no surgery, oral antibiotics, and local incision care; (2) surgical debridement, IV antibiotics, and implant retention; (3) one-stage explantation, IV antibiotics, and reimplantation generally with conversion to total hip replacement; and (4) two-stage reimplantation with conversion to total hip replacement. Mean follow-up was 9 years (range, 2-34). Pretreatment qualitative themes found that some patients believed their early infection symptoms were not validated, leading to diagnostic delays. During treatment, themes centered on mobility and lifestyle limitations for those receiving revision surgery. Posttreatment themes were reduced function following revision compared to pretreatment function. Of the 301 patients, 199 (66%) had nonoperative care, with remission for 169 (85%); 40 (13%) had one-stage reimplantation and 36 (90%) had infection remission; 16 (5%) had two-stage reimplantation with remission in 14 (87%); and 46 (16%) had debridement and implant retention, with remission for 38 (83%). The matrix showed that patients with infected HRA preferred nonoperative care, which was successful for 85%. Qualitative themes found less patient distress with nonoperative treatment and the greatest patient distress with two-stage revision.

参考

  1. Darouiche RO. Treatment of infections associated with surgical implants. N Eng J Med. 2004;350:1422-9. .

  2. Odom GL, Finney W, Woodhall B. Cervical disk lesions. J Am Med Assoc. 1958:166:23-8. .

  3. Pritchett JW. Curved-stem hip resurfacing: Minimum 20 year followup. Clin Orthop Relat Res. 2008;466:1177-85. .

  4. McPherson EJ, Tontz W Jr, Patzakis M, Woodsome C, Holtom P, Norris L, Shufelt C. Outcome of infected total knee utilizing a staging system for prosthetic joint infection. Am J Orthop (Belle Mead NJ). 1999;28:161-5. .

  5. Morris SZ, Wooding S, Grant J. The answer is 17 years, what is the question: Understanding time lags in translational research. J R Soc Med. 2011;104:510-20. .

  6. Pritchett JW. Polyethylene hip resurfacing worth a second look. Ann Joint. 2020;5:10-20. .

  7. Pugh S. Concept selection: A method that works. In: Hubka V, editor. Design methodology. Proceedings of the International Conference of Engineering Design. Zurich, Switzerland: Heurista; 1981. p. 497-506. .

  8. Bhargava A, Salim M, Banavasi HV, Neelam V, Wenzel R, Sims KL, Char S, Kaye KS. Surgical site infections following Birmingham hip resurfacing. Infect Control Hosp Epidemiol. 2016;37:1383-6. .

  9. Diaz-Ledezma C, Higuera CA, Parvizi J. Success after treatment of periprosthetic joint infection: A Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res. 2013:471:2374-82. .

  10. Kapoor A, Reading AD, Luscombe JC. Revision of well-fixed Birmingham hip resurfacing using the Explant system and cement mould. A useful technique. Eur J Orthop Surg Traumatol. 2007;17:381-3. .

  11. Bryan AJ, Abdel MP, Sanders TL, Fitzgerald SF, Hanssen AD, Berry DJ. Irrigation and debridement for acute infection after hip arthroplasty. Improved results with contemporary management. J Bone Joint Surg Am. 2017;99A:2011-8. .

  12. Mallon C, Gooberman-Hill R, Blom A, Whitehouse M, Moore A. Surgeons are deeply affected when patients are diagnosed with prosthetic joint infection. PLoS One. 2018;13:e0207260. .

  13. Aufranc OE. Management of infections about the hip. In Constructive Surgery of the Hip. St. Louis, MO: CV Mosby; 1962. p. 181-90. .

  14. Harris WH, Aufranc OE. Mould arthroplasty in treatment of hip fractures complicated by sepsis. J Bone Joint Surg Am. 1965;47A:31-42. .

  15. Leddy J, Grantham A, Stinchfield FE. Hip-mold arthro-plasty and postoperative infection. A method of salvage used in 10 patients. J Bone Joint Surg. 1971;53:37-46. .

  16. Coughlan A, Taylor F. Classifications in brief: The McPherson classification of prosthetic infection. Clin Orthop Relat Res. 2020;478:903-8. .

  17. Moore AJ, Blom AW, Whitehouse MR, Gooberman-Hill R. Deep prosthetic infection: A qualitative study of the impact on patients and their experiences of revision surgery. BMJ Open. 2015;7:e009495. .

  18. Wagner H. Surface replacement arthroplasty of the hip. Clin Orthop Relat Res. 1978;134:102-30. .

  19. Broekema AEH, Molenberger R, Kuijlen JMA, Groen RJM, Reneman JF, Soer R. The Odom criteria: Validated at last: A clinometric evaluation in cervical spine surgery. J Bone Joint Surg Am. 2019;101:1301-8. .

  20. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR; Infectious Diseases Society of America. Executive summary: Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the Infectious Diseases Society ofAmerica. Clin Infect Dis. 2013: 56:1-10. .

  21. Anthony SJ, Cooper LG. Use of orvitavancin (novel new lipoglycopeptide) in the treatment of prosthetic joint infec-tions (PJI): A possible alternative novel approach to a difficult problem. Infect Disord Drug Targets. 2017;17:77-80. .

  22. Gomez MM, Tan TL, Manrique J, Deirmengian GK, Parvizi J. The fate of spacers in the treatment of periprosthetic joint infection. J Bone Joint Surg Am. 2015;97:1495-502. .

  23. Bierbaum BE, Sweet R. Complications of resurfacing arthroplasty. Orthop Clin North Am. 1982;13:761-75. .

  24. Daniel J, Pradhan C, Ziaee H, Pynsent PB, McMinn DJW. Results of Birmingham hip resurfacing at 12 to 15 years. Bone Joint J. 2014;96B:1298-306. .

  25. Senard O, Houselstein T, Cremieux AC. Reasons for litigation in arthroplasty infections and lessons learned. J Bone Joint Surg Am. 2019;101:1806-11. .

  26. Townley CO, Walker SC. Intramedullary cupstem arthroplasty of the hip. J Bone Joint Surg Am. 1961;43: 602. .

  27. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Foreign-body infection (FBI) study group. J Am Med Assoc. 1998;279:1537-41. .

  28. Alverdy JC. Microbiome medicine: This changes every-thing. J Am Coll Surg. 2018;226:719-29. .

  29. Thompson JM, Saini V, Ashbaugh AG, Miller RJ, Ordone AA, Ortines RV, Wang Y, Sterling RS, Jain SK, Miller LS. Oral-only linezolid-rifampin is highly effective compared with other antibiotics for periprosthetic joint infection: Study of a mouse model. J Bone Joint Surg Am. 2017;99:656-65. .

  30. Townley CO. Complications in total hip replacement. Ceramic Trans. 1995;48:23-34. .

  31. Donker GA, Wiersma E, van der Hoek L, Hein SM. Determinants of general practitioner's cancer-related gut-feelings-a prospective cohort study. BMJ Open. 2016;13:6(9):e012511. .


Articles with similar content:

The Influence of Capsulotomy for Intracapsular Hip Fractures
Journal of Long-Term Effects of Medical Implants, Vol.28, 2018, issue 3
Jacob J. Triplet, Benjamin C. Taylor, Brian Sullivan
Programmatic Effectiveness of a University-Based Implant Training Program: Long-Term, Patient-Centered Outcomes
Journal of Long-Term Effects of Medical Implants, Vol.20, 2010, issue 4
A. Branscum, Fonda G. Robinson, S. J. Jasper, Mark V. Thomas, M. M. Farino, Mohanad Al-Sabbagh, David A. Puleo
Review of Lower Extremity Function Following SEMLS in Children with Cerebral Palsy
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.31, 2019, issue 2
Ashok Johari, Sailaxmi Ganesan, Triveni Shetty, Rajani Mullerpatan
Risk of Bacteremia in Patients with Hematological and other Malignancies after Initial Placement of a Central Venous Catheter
Journal of Long-Term Effects of Medical Implants, Vol.17, 2007, issue 4
Mette Norgaard, Gitte Pedersen, Henrik Carl Schonheyder, Petra Witt Andersen, Erik Stolberg, Henrik Toft Sorensen, Heidi Larsson, Mathilda Kiiveri
Effectiveness of the Dynamic Internal Fixator System in Metaphyseal and Epiphyseal Femoral Fractures: 10 Years of Experience and Future Expectations
Journal of Long-Term Effects of Medical Implants, Vol.29, 2019, issue 2
Francesco Saverio Sirabella, Andrea Angelini, Francesca Giovannini, Concetto Battiato, Pietro Ruggieri